To the editor — Most US- and European-based drug makers that produce biosimilar products use decades-old processes for manufacturing. Although there is no business incentive for Western manufacturers to innovate in downstream processes, the situation is very different in emerging economies. Here, we highlight two Indian companies — Biocon and Enzene Biosciences (of Alkem Laboratories) — that have boosted their competitiveness in local markets by investing in process innovation in manufacturing, enabling a reduction in costs without compromising product safety and quality. We propose that their approach could be adopted on a wider scale by other companies in emerging economies, especially where there are several market entrants seeking to gain a competitive edge. Moreover, as emerging economies continue to grow, we believe that investment in process-side innovation can provide firms in emerging economies with a competitive edge over larger counterparts in developed economies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
92,52 €
only 7,71 € per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Mulcahy, A. W., Hlavka, J. P. & Case, S. R. Rand Health Q. 7, 3 (2018).
Rathore, A. S. & Shereef, F. Nat. Biotechnol. 37, 498–501 (2019).
Rathore, A. S. & Bhargava, A. Prep. Biochem. Biotechnol. 51, 1–8 (2021).
Bloomberg L.P. Annual reported financials data for major biotech and pharmaceutical companies worldwide 1/1/15 to 31/12/21 (Bloomberg Terminal, accessed 19 March 2022).
FactSet Research Systems Inc. Annual reported financials data for major biotech and pharmaceutical companies worldwide 1/1/15 to 31/12/21 (FactSet Financial Data and Analytics, accessed 19 March 2022).
Acknowledgements
The authors thank Narahari Chittoor Rao and Himanshu Gadgil from Enzene Biosciences Limited and Nihal George, Manjiri Kulkarni, Vaishali Sethi and Shreehas Tambe from Biocon Biologics Limited for input about their respective companies.
Ethics declarations
Competing interests
The authors declare no competing interests.
About this article
Cite this article
Rathore, A., Shereef, F. Innovating manufacturing technology in emerging economies. Nat Biotechnol (2022). https://doi.org/10.1038/s41587-022-01499-5
Published:
DOI: https://doi.org/10.1038/s41587-022-01499-5
Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here